AngioDynamics (ANGO) News Today $9.45 +0.04 (+0.43%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$9.47 +0.02 (+0.25%) As of 05/23/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period AngioDynamics, Inc. (NASDAQ:ANGO) Position Trimmed by Millennium Management LLCMillennium Management LLC lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,162,568 shares oMay 23 at 4:09 AM | marketbeat.comD. E. Shaw & Co. Inc. Has $2.26 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)D. E. Shaw & Co. Inc. increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 247,074 shares of the medical instruments supplier's stock after acquiring an adMay 23 at 3:42 AM | marketbeat.comParadigm Capital Management Inc. NY Takes Position in AngioDynamics, Inc. (NASDAQ:ANGO)Paradigm Capital Management Inc. NY bought a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 404,001 shares of the medical instruments supplierMay 22 at 8:00 AM | marketbeat.comSystematic Financial Management LP Has $23.09 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Systematic Financial Management LP boosted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 4.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,521,065 shares of the medical iMay 19, 2025 | marketbeat.com185,245 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. purchased a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 185,245 shareMay 19, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires 107,829 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Jacobs Levy Equity Management Inc. boosted its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 26.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 521,949 shares of the medical instruments supplier's stock after buying an addiMay 17, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Holdings Lifted by Balyasny Asset Management L.P.Balyasny Asset Management L.P. lifted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 77.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 110,851 shares of the medical instruments supplier's stock after buying an additiMay 17, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stake Reduced by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 46.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 135,350 shares of the medical instMay 16, 2025 | marketbeat.comBridgeway Capital Management LLC Has $324,000 Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Bridgeway Capital Management LLC trimmed its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 60.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,400 shares of the medical instruments supplier's stock after sMay 15, 2025 | marketbeat.comTudor Investment Corp ET AL Sells 115,929 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Tudor Investment Corp ET AL lowered its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 85.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,838 shares of the medical instrumentMay 13, 2025 | marketbeat.comDimensional Fund Advisors LP Has $13.64 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Dimensional Fund Advisors LP increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,488,667 shares ofMay 11, 2025 | marketbeat.com514,635 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Divisadero Street Capital Management LPDivisadero Street Capital Management LP acquired a new stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 514,635 shares of the medical instrumentMay 9, 2025 | marketbeat.comManatuck Hill Partners LLC Increases Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Manatuck Hill Partners LLC grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 166.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 199,500 shares of the medical instruments supplier's stockMay 4, 2025 | marketbeat.comAngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound?May 2, 2025 | msn.comZacks Research Expects Increased Earnings for AngioDynamicsAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities researchers at Zacks Research raised their FY2025 earnings estimates for shares of AngioDynamics in a report issued on Wednesday, April 23rd. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will poApril 27, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Marshall Wace LLPMarshall Wace LLP grew its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 1,335.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 476,824 shares of the medical instruments supplier's stockApril 27, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Holdings Lessened by Renaissance Technologies LLCRenaissance Technologies LLC reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 913,029 shares of the medical instruments supplier's stock after sellingApril 20, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 254,322 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)JPMorgan Chase & Co. increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 807,483 shares of the medical instruments supplier's stock after acquiring an additional 2April 19, 2025 | marketbeat.comTrexquant Investment LP Reduces Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Trexquant Investment LP lessened its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 81,771 shares of the medical instruments supplier's stock afterApril 14, 2025 | marketbeat.comPrudential Financial Inc. Trims Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Prudential Financial Inc. lessened its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,366 shares of the medicaApril 13, 2025 | marketbeat.comHC Wainwright Lifts Earnings Estimates for AngioDynamicsAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Analysts at HC Wainwright lifted their FY2025 earnings per share estimates for AngioDynamics in a research note issued on Monday, April 7th. HC Wainwright analyst Y. Chen now expects that the medical instruments supplier will post earnings per shaApril 12, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Raises Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Arrowstreet Capital Limited Partnership increased its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 293.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 352,544 shares of the medical instruApril 11, 2025 | marketbeat.comShareholders in AngioDynamics (NASDAQ:ANGO) are in the red if they invested three years agoApril 8, 2025 | finance.yahoo.comAngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPSAngioDynamics (NASDAQ:ANGO - Get Free Report) issued its quarterly earnings data on Wednesday. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year.April 5, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Updates FY25 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY25 earnings guidance. The company provided EPS guidance of ($0.34)-($0.31) for the period, compared to the consensus estimate of ($0.37). The company also issued revenue guidance of $285-288 millionillion, compared to the consensus estimate of $284.89 millionillion.April 4, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2025 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.340--0.310 for the period, compared to the consensus estimate of -0.370. The company also issued revenue guidance of $285.0 millionillion-$288.0 millionillion, compared to the consensus estimate of $284.9 millionillion.April 4, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Trims Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)Mitsubishi UFJ Asset Management Co. Ltd. trimmed its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 23.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 141,160 shares of the medical instruments supApril 4, 2025 | marketbeat.comAngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoptionApril 3, 2025 | msn.comAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call TranscriptApril 3, 2025 | insidermonkey.comStoneX Group Inc. Takes $981,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO)StoneX Group Inc. bought a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 107,083 shares of the medical instruments supplier's stock, valued at approximately $981,000. StoneX Group Inc. owned aApril 3, 2025 | marketbeat.comAngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 3, 2025 | gurufocus.comAngioDynamics reports Q3 adjusted EPS (8c), consensus (13c)April 3, 2025 | markets.businessinsider.comAngioDynamics up 13% in pre-market at $10.90 after Q3 results, guidance raiseApril 3, 2025 | markets.businessinsider.comQ3 2025 AngioDynamics Inc Earnings Call TranscriptApril 3, 2025 | gurufocus.comMedical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual GuidanceApril 2, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventApril 2, 2025 | tipranks.comAngioDynamics 3Q Loss Narrows as Operating Expenses Slim DownApril 2, 2025 | marketwatch.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | investing.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | businesswire.comUncovering Potential: AngioDynamics's Earnings PreviewApril 1, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventMarch 31, 2025 | finance.yahoo.comAngioDynamics Q3 EPS Forecast Decreased by Zacks ResearchAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Research analysts at Zacks Research cut their Q3 2026 EPS estimates for shares of AngioDynamics in a research report issued to clients and investors on Tuesday, March 25th. Zacks Research analyst D. Dey now forecasts that the medical instruments sMarch 29, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $12.96 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Segall Bryant & Hamill LLC boosted its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 55.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,415,156 shares of the medical instruments supplier's stock afteMarch 27, 2025 | marketbeat.comAngioDynamics (ANGO) Expected to Announce Earnings on WednesdayAngioDynamics (NASDAQ:ANGO) will be releasing earnings before the market opens on Wednesday, April 2, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=676576)March 26, 2025 | marketbeat.comAngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host ...March 19, 2025 | gurufocus.comAngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor EventMarch 19, 2025 | businesswire.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by Royce & Associates LPRoyce & Associates LP increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,119,385 shares of the medical instruments supplier'March 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $3.56 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Connor Clark & Lunn Investment Management Ltd. lifted its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 69.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 389,053 shares of the medMarch 18, 2025 | marketbeat.comAngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual ConferenceMarch 10, 2025 | finance.yahoo.comQ2 EPS Estimates for AngioDynamics Lifted by Zacks ResearchAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities research analysts at Zacks Research lifted their Q2 2026 EPS estimates for shares of AngioDynamics in a report issued on Thursday, March 6th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earnMarch 10, 2025 | marketbeat.com Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANGO Media Mentions By Week ANGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼1.690.77▲Average Medical News Sentiment ANGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼53▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Integra LifeSciences News Today Orthofix Medical News Today Surmodics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Boston Scientific News Today Stryker News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANGO Stock Free ANGO Stock Alerts